SATOH Tohru | Department of Cardiology,Ashikaga Red Cross Hospital
スポンサーリンク
概要
関連著者
-
SATOH Tohru
Department of Cardiology,Ashikaga Red Cross Hospital
-
TAKEHARA Kazuhiko
Department of Dermatology, Kanazawa University Hospital
-
YAMADA Norikazu
Department of Cardiology, Mie University Graduate School of Medicine
-
NAKANISHI Norifumi
Division of Cardiology, National Cardiovascular Center
-
Shimada Megumi
Department of internal Medicine, School of Medicine, Keio University
-
Watanabe Hiroshi
Department of Cardiology, Niigata City General Hospital
-
Shimada Megumi
Department Of Cardiology Ashikaga Red Cross Hospital
-
CHINO Masao
Department of Cardiology,Ashikaga Red Cross Hospital
-
UNO Keiko
Department of Cardiology,Ashikaga Red Cross Hospital
-
OHOIDA Akitsugu
Department of Cardiology,Ashikaga Red Cross Hospital
-
KUSUHARA Masatoshi
Department of Cardiology,Ashikaga Red Cross Hospital
-
Ogawa Satoshi
Department Of Cardiology Keio University
-
Kusuhara Masatoshi
Department Of Cardiology Ashikaga Red Cross Hospital
-
Kusuhara Masatoshi
Department Of Cardiology
-
Kuriyama Takayuki
Department of Chest Medicine, School of Medicine, Chiba University
-
Chino Masao
Department Of Cardiology
-
Tanabe Nobuhiro
Department Of Respirology Chiba Graduate School Of Medicine
-
Miyaji Katsumasa
Department Of Cardiology National Hospital Organization Okayama Medical Center
-
Yao Atsushi
Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine
-
Uno Keiko
Department Of Cardiology Ashikaga Red Cross Hospital
-
Saji Tsutomu
First Department of Pediatrics, Toho University Omori Medical Center
-
Suzuki Yumiko
Tokyo Laboratories, Pfizer Global R&D, Pfizer Japan Inc
-
Fujiwara Tadami
Tokyo Laboratories, Pfizer Global R&D, Pfizer Japan Inc
-
Chino Masao
Department Of Cardiology Ashikaga Red Cross Hospital
-
Satoh Tohru
Department Of Cardiology Ashikaga Red Cross Hospital
-
Ohoida Akitsugu
Department Of Cardiology Ashikaga Red Cross Hospital
著作論文
- ESTIMATED NUMBER OF CASES NECESSARY FOR INTERVENTION TRIAL OF ISCHEMIC HEART DISEASE:A STUDY IN PATIENTS WITH TRIPLE VESSEL DISEASE
- A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension